KIU Publications

Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.

Scholarly Work

KIU publications archive

Search peer-reviewed articles, reports, books, policy briefs and other scholarly outputs by KIU researchers and collaborators.

Reset
5,548 results found Use the filters to narrow results by title, author, section, publication year or keyword.
2026 School of Pharmacy

Phytochemical Nanoformulations for Insulin Resistance and β-Cell Protection in Diabetes

Nabuuma Ruth Nambi

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 119-130

Insulin resistance and progressive pancreatic β-cell failure are the twin biological engines of type 2 diabetes and major determinants of long-term complications. Phytochemicals such as curcumin, resveratrol, quercetin, epigallocatechin gallate, berberine, gi...

2026 School of Pharmacy

Patient Experiences in HIV Care: A Qualitative Review from Ugandan Hospitals

Ssenkayi Julius

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 114-118

Ugandan HIV services have expanded rapidly, improving access and clinical outcomes; however, this review indicates that patient experience remains uneven, particularly in hospital-based settings. Reported problems cluster around stigma, confidentiality breach...

2026 School of Pharmacy

Next-Generation Nanomedicine for Obesity and Diabetes: Mechanisms, Challenges, and Translational Opportunities: A Mini-Review

Namirimu Sandrah

2026 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 61-66

Obesity and type 2 diabetes (T2D) are major contributors to the global health crisis, characterized by insulin resistance, impaired glucose metabolism, and systemic inflammation. The progression of these metabolic disorders is driven by the dysfunction of key...

2026 School of Pharmacy

Neuroimmune Crosstalk in Chronic Pain Syndromes: Emerging Roles of Glial Cells and Cytokines

Serunjogi Ruth

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 109-113

Chronic pain syndromes represent a significant global health burden, characterized by persistent pain that extends beyond normal tissue healing. Once considered a purely neuronal phenomenon, chronic pain is now recognized as a complex neuroimmune disorder inv...

2026 School of Pharmacy

Natural Product–Based Nanocarriers for Precision Glycemic Control: Innovations in Diabetes Nanomedicine

Serunjogi Ruth

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 102-108

Diabetes mellitus (DM) is a complex metabolic disorder characterized by chronic hyperglycemia and progressive vascular complications. Despite advances in pharmacotherapy, achieving sustained glycemic control without adverse effects remains challenging. Natura...

2026 School of Pharmacy

Nanotechnology-Based Interventions for Obesity Associated Insulin Resistance and Diabetes Progression

Mercy Latricia

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 90-95

Obesity is a leading risk factor for the development of insulin resistance and type 2 diabetes (T2D), creating a global health crisis. Insulin resistance, characterized by the inability of cells to respond to insulin effectively, is at the core of both obesit...

2026 School of Pharmacy

Nanotechnology at the Metabolic Interface: Emerging Solutions for Obesity-Driven Diabetes

Winniefred Nankya

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 96-101

Obesity and type 2 diabetes (T2D) are increasingly prevalent global health issues, often coexisting as part of a metabolic syndrome characterized by insulin resistance and chronic inflammation. Recent advances in nanotechnology offer innovative solutions to a...

2026 School of Pharmacy

Nanostructured Lipid Carriers for Artemisinin Delivery: Overcoming Resistance in Severe Pediatric Malaria

Nasira A. Sitar

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 85-89

Severe pediatric malaria remained a leading cause of morbidity and mortality in sub–Saharan Africa and parts of Southeast Asia, despite widespread deployment of artemisinin-based combination therapies. Artemisinin derivatives acted rapidly against Plasmodium...

2026 School of Pharmacy

Nanoencapsulation of Natural Lipid-Modulating Agents for Obesity-Induced Dyslipidemia

Taliikwa Nicholas Ceaser

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 77-84

Obesity-induced dyslipidemia, typically characterized by elevated triglycerides, increased small dense LDL, and reduced HDL functionality, is a major mediator of cardiovascular risk in metabolic disease. Natural lipidmodulating agents such as polyphenols, phy...

2026 School of Pharmacy

Nanoencapsulation of Natural Antioxidants for Diabetic Complications: Mechanisms and Clinical Prospects

Taliikwa Nicholas Ceaser

2026 | IDOSR JOURNAL OF SCIENTIFIC RESEARCH | Pp. 69-76

Chronic hyperglycemia in diabetes mellitus drives excessive reactive oxygen species (ROS) generation, mitochondrial dysfunction, advanced glycation end-product (AGE) formation, and persistent inflammation, collectively contributing to microvascular and macrov...